Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 104545
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104545
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104545
Table 5 Univariate analysis of subjective computed tomography signs, n (%)
| CT imaging features | Chemotherapy ineffective group (n = 35) | Chemotherapy effective group (n = 62) | χ2 | P value |
| Hickness change rate | 16.524 | < 0.001 | ||
| < 40% | 26 (74.29) | 23 (37.10) | ||
| 40% | 9 (25.71) | 39 (62.90) | ||
| Gastric wall motility | 13.682 | < 0.001 | ||
| Present | 11 (31.43) | 42 (67.74) | ||
| Absent | 24 (68.57) | 20 (32.26) | ||
| Lesion enhancement pattern | 7.845 | 0.005 | ||
| Type A | 13 (37.14) | 40 (64.52) | ||
| Type B | 22 (62.86) | 22 (35.48) | ||
| Lymph node metastasis | 2.246 | 0.134 | ||
| N0 | 15 (42.86) | 36 (58.06) | ||
| N+ | 20 (57.14) | 26 (41.94) | ||
| Peritoneal thickening and nodules | 6.235 | 0.013 | ||
| None | 16 (45.71) | 43 (69.35) | ||
| Present | 19 (54.29) | 19 (30.65) |
- Citation: Wang CY, Zhang L, Ma JW. Computed tomography 3D reconstruction and texture analysis for evaluating the efficacy of neoadjuvant chemotherapy in advanced gastric cancer. World J Gastrointest Surg 2025; 17(6): 104545
- URL: https://www.wjgnet.com/1948-9366/full/v17/i6/104545.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.104545